Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-012636
Filing Date
2023-11-17
Accepted
2023-11-17 12:36:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27650
2 filename2.txt TEXT-EXTRACT 1496
  Complete submission text file 0000000000-23-012636.txt   40579
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filed for) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)